Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 20, 2022

Concurrent Olaparib and Radiotherapy in Patients With TNBC

JAMA Oncology


Additional Info

JAMA Oncology
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
JAMA Oncol 2022 Oct 27;[EPub Ahead of Print], P Loap, D Loirat, F Berger, M Rodrigues, L Bazire, JY Pierga, A Vincent-Salomon, F Laki, L Boudali, L Raizonville, V Mosseri, A Jochem, A Eeckhoutte, M Diallo, MH Stern, A Fourquet, Y Kirova

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading